Back to Journals » Therapeutics and Clinical Risk Management » Volume 11

The relationship between eosinophilia and slow coronary flow

Authors Altas Y, Kurtoğlu E, Yaylak B, Baysal E, Ucaman B, Ugurlu M, Karahan M, Altintas B, Adiyaman MS, Kaya I, Erdolu U, Ozen K, Cakir C, Sevuk U

Received 1 May 2015

Accepted for publication 7 July 2015

Published 12 August 2015 Volume 2015:11 Pages 1187—1191


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Editor who approved publication: Professor Garry Walsh

Yakup Altas,1 Ertugrul Kurtoglu,2 Baris Yaylak,1 Erkan Baysal,1 Berzal Ucaman,1 Hasan Murat Ugurlu,1 Mehmet Zülkif Karahan,1 Bernas Altintas,1 Mehmet Sahin Adiyaman,1 İlyas Kaya,1 Umut Erdolu,1 Kaya Ozen,1 Cayan Cakir,3 Utkan Sevuk4

1Department of Cardiology, Diyarbakir Gazi Yasargil Education and Research Hospital, 2Department of Cardiology, Malatya State Hospital, Malatya, 3Department of Cardiology, Memorial Diyarbakir Hospital, 4Department of Cardiovascular Surgery, Diyarbakir Gazi Yasargil Education and Research Hospital, Diyarbakir,Turkey

Aim: The pathophysiology of slow coronary flow (SCF) involves atherosclerosis, small vessel dysfunction, platelet function disorders, and inflammation. It has been known that eosinophils also play a significant role in inflammation, vasoconstriction, thrombosis, and endothelial dysfunction. We propose to evaluate the relationship between eosinophilia and SCF.
Methods: All patients who underwent coronary angiography between January 2011 and December 2013 were screened retrospectively. Of 6,832 patients, 102 patients with SCF (66 males, mean age 52.2±11.7 years) and 77 control subjects with normal coronary angiography (50 males, mean age 50.7±8.1 years) were detected. Baseline characteristics, hematological test results, and biochemical test results were obtained from the hospital database.
Results: Baseline characteristics of the study groups were comparable between groups. There was no significant difference between groups regarding leukocyte count, paletelet count, and mean platelet volume. However, patients with SCF had a higher eosinophil count than the controls (0.24±0.17×103/µL vs 0.16±0.15×103/µL, P=0.002). In addition, eosinophil count was found to be correlated with thrombolysis in myocardial infarction (TIMI) frame count in the SCF group (r=0.3, P<0.01). There was no significant correlation between eosinophil count and the number of coronary arteries showing slow flow.
Conclusion: Patients with SCF have higher blood eosinophil count, and this may play an important role in the pathogenesis of SCF. Elevated baseline eosinophil count may indicate the presence of SCF.

Keywords: eosinophilia, slow coronary flow, coronary angiography

A Letter to the editor has been received and published for this article.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]